Portal de investigación
ESTUDIO OBSERVACIONAL, RETROSPECTIVO, MULTICÉNTRICO PARA EVALUAR LOS SÍNTOMAS NO MOTORES EN PACIENTES CON ENFERMEDAD DE PARKINSON AVANZADA TRATADOS CON ROTIGOTINA.
Datos básicos
- Protocolo:
- UCB-ROT-2011-01
- EUDRACT:
- NCT:
- Centro:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
A 3.9-Mb Deletion on 2p11.2 Comprising the REEP1 Gene Causes Early-Onset Atypical Parkinsonism.
Baviera-Muñoz R; (...); Espinós C
Article. 10.1212/NXG.0000000000000642. 2021
Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study.
Freire-Alvarez, Eric; (...); Escamilla-Sevilla, Francisco
Article. 10.1016/j.compbiomed.2024.109504. 2024
Clinical and genetic characteristics of 21 Spanish patients with biallelic pathogenic SPG7 mutations.
Baviera-Muñoz R; (...); Espinós C
Article. 10.1016/j.jns.2021.118062. 2021
Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.
Baviera-Munoz, Raquel; (...); Aller, Elena
Article. 10.1212/NXG.0000000000200038. 2022
Efectos adversos y complicaciones de la infusión intestinal continua de levodopa-carbidopa en una cohorte de pacientes con enfermedad de Parkinson de un hospital terciario.
Campins-Romeu, Marina; (...); Martinez-Torres, Irene
Article. 10.33588/rn.7405.2021482. 2022
Effectiveness and safety of levodopa-entacapone-carbidopa infusion in Parkinson disease: A real-world data study.
Santos-García D; (...); Mata M
Article. 10.1111/ene.16535. 2024
Estimulación cerebral profunda combinada del núcleo subtalámico y el globo pálido interno en la enfermedad de Parkinson.
Campins-Romeu M; (...); Martínez-Torres I
Case Reports. 10.33588/rn.7703.2022250. 2023
Gait Function after High-Intensity Focused Ultrasound Thalamotomy for Essential Tremor: Searching for Technique Optimization.
Sastre-Bataller, Isabel; (...); Martinez-Torres, Irene
Article. 10.1159/000527374. 2023
Hereditary Spastic Paraplegia 7 Presenting as Multifocal Dystonia with Prominent Cranio-Cervical Involvement
Campins-Romeu, M; (...); Martinez-Torres, I
Letter. 10.1002/mdc3.13257. 2021
MNCD: A New Tool for Classifying Parkinson's Disease in Daily Clinical Practice.
Santos García D; (...); Ignacio, AS
Article. 10.3390/diagnostics12010055. 2021
MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing Lesion Volume
Campins-Romeu, Marina; (...); Martinez-Torres, Irene
Article. 10.1038/s41531-024-00843-7. 2024
MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing Lesion Volume (vol 10, 230, 2024)
Campins-Romeu, Marina; (...); Martinez-Torres, Irene
Correction. 10.1038/s41531-025-00871-x. 2025
Mutations, genes and phenotypes related to movement disorders: a never-ending list
Martinez-Rubio, Dolores; (...); Espinos, Carmen
Meeting Abstract. 2022
Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel
Baviera-Munoz, R.; (...); Martinez-Torres, I.
Letter. 10.1016/j.nrl.2021.10.002. 2022
Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel.
Baviera-Muñoz R; (...); Martinez-Torres I
Article. 10.1016/j.nrleng.2021.10.002. 2022
Smoking is associated with age at disease onset in Parkinson's disease.
Rosas I; (...); Bandrés-Ciga S
Article. 10.1016/j.parkreldis.2022.03.005. 2022
Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain
Baviera-Munoz, Raquel; (...); Bataller, Luis
Article. 10.1002/mdc3.13740. 2023
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life.
Santos-Garcia, Diego; (...); Mir, Pablo
Article. 10.3233/JPD-225073. 2023
STUB1 Mutations as Possible Genetic Modifiers in Spinocerebellar Ataxia Type 8.
Baviera-Munoz, Raquel; (...); Aller, Elena
Article. 10.1002/mds.29910. 2024
Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease
Santos-Garcia, Diego; (...); Alvarez-Santullano, Marina Mata
Article. 10.3390/brainsci14121244. 2024